Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
338 studies found for:    "hemophilia"
Show Display Options
Rank Status Study
1 Suspended Study of Ataluren (PTC124®) in Hemophilia A and B
Conditions: Hemophilia A;   Hemophilia B
Intervention: Drug: Ataluren (PTC124)
2 Completed
Has Results
Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor
Conditions: Hemophilia A;   Hemophilia B;   (High-titer) Factor VIII Inhibitor;   (High-titer) Factor IX Inhibitor
Intervention: Biological: Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)
3 Completed Study Evaluating Approach to Treatment of Haemophilia A and B in Spain
Conditions: Hemophilia A;   Hemophilia B
Intervention:
4 Completed Survey Evaluating the Psychosocial Effects of Living With Haemophilia
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia B;   Haemophilia A With Inhibitors;   Haemophilia B With Inhibitors;   Relatives to/Carers of Patients
Intervention: Other: No treatment given
5 Unknown  Socialization of Adult Men With Congenital Hemophilia A or B
Conditions: Hemophilia A;   Hemophilia B
Intervention:
6 Completed Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia A With Inhibitors;   Haemophilia B;   Haemophilia B With Inhibitors
Intervention: Other: No treatment given
7 Completed Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia A With Inhibitors;   Haemophilia B;   Haemophilia B With Inhibitors
Intervention: Other: No treatment given
8 Recruiting Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
Conditions: Hemophilia A;   Hemophilia B;   Von Willebrand's Disease
Intervention:
9 Completed A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia A With Inhibitors;   Haemophilia B;   Haemophilia B With Inhibitors
Intervention: Drug: eptacog alfa (activated)
10 Terminated Osteoporosis and MRI Study in Hemophilia
Conditions: Bone Mineral Density;   Hemophilia A;   Hemophilia B
Intervention: Other: DXA scan + MRI
11 Active, not recruiting Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia
Conditions: Hemophilia A;   Hemophilia B;   Vitamin D Deficiency
Intervention: Dietary Supplement: Vitamin D and calcium
12 Completed Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World
Conditions: Hemophilia A;   Hemophilia B
Intervention:
13 Active, not recruiting An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia
Conditions: Hemophilia A;   Hemophilia B;   Factor VIII Deficiency;   Factor IX Deficiency
Intervention: Device: Accelerometer
14 Completed Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study
Conditions: Hemophilia A;   Hemophilia B
Intervention:
15 Completed Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Conditions: Hemophilia A;   Hemophilia B
Intervention:
16 Active, not recruiting Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia B
Intervention: Drug: activated recombinant human factor VII
17 Completed Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia B
Intervention: Drug: activated recombinant human factor VII
18 Recruiting A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients
Conditions: Hemophilia A;   Hemophilia B
Interventions: Drug: ALN-AT3SC;   Drug: Sterile Normal Saline (0.9% NaCl)
19 Completed Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia B
Intervention: Drug: NNC 0128-0000-2011
20 Completed Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia B;   Healthy
Interventions: Drug: NNC 0172-0000-2021;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years